StocksMedium•16 October 2026•
1 min read
Moleculin Biotech Announces 1-for-20 Reverse Stock Split
Key Facts
1Moleculin Biotech announced a 1-for-20 reverse stock split of its common stock to take effect on October 20, 2026.
2The company's common stock will open for trading on The Nasdaq Capital Market on a post-split basis under the existing ticker MBRX.
Moleculin Biotech announced a 1-for-20 reverse stock split of its common stock to take effect on October 20, 2026. GlobeNewswire reported that the company's common stock will open for trading on The Nasdaq Capital Market on a post-split basis under the existing ticker MBRX at the market open on that date.
Under the terms of the split, every 20 shares of issued and outstanding common stock will be consolidated into one share with no change in par value. MBRX closed at $0.3701 on October 15, 2026, with the stock trading between a day low of $0.3701 and a high of $0.426 during that session.